EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
Authors:
Open Access
- 1 September 2019
- journal article
- editorial
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 15 (3) , 244-246
Abstract
In the EOLIA trial, early use of ECMO did not significantly improve mortality at 60 days in patients with severe ARDS, but when used as a rescue modality ECMO might help improve survivalhttp://bit.ly/2XOjwSEKeywords
This publication has 13 references indexed in Scilit:
- Acute Respiratory Distress SyndromeJAMA, 2018
- Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trialAnnals of Oncology, 2017
- Extracorporeal membrane oxygenation in adults: A practical guide for internistsCleveland Clinic Journal of Medicine, 2016
- Extracorporeal Membrane Oxygenation for Pandemic Influenza A(H1N1)–induced Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2013
- The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaksIntensive Care Medicine, 2011
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromeJAMA, 2009
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Randomized Clinical Trial of Pressure-Controlled Inverse Ratio Ventilation and Extracorporeal CO2 Removal for Adult Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Extracorporeal Membrane Oxygenation in Severe Acute Respiratory FailureJAMA, 1979
- Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective studyJAMA, 1979